Final Program
This is the final conference program. By clicking the button, you can download it.
| Time | Tuesday – September 2 | Wednesday – September 3 | Thursday – September 4 | Friday – September 5 |
|---|---|---|---|---|
| 9h00 |
9h00
PL 02
Pathogenic mAbs, large metastable immune complexes and activated platelets: mass spectrometry reveals the mechanism of a deadly vaccine side effect
|
9h00
PL 03
How far are we from a complete and reliable compositional assessment of natural extracts: Perspectives for the development of new ingredients and drug discovery
|
9h00
KN 10
Advances in mass spectrometry imaging for pharmaceutical R&D: Simplification for Non-experts, Single-cell Metabolomics, 3D-MSI of Organoids, and more Analytical Depth for Advanced Spatial Lipidomics
|
|
| 9h30 |
9h30
OC 12
Recent development in the Analysis of RadioPharmaceuticals
|
|||
| 9h45 |
9h45
KN 02
Advances in capillary electrophoresis applications for drug development and quality control
|
9h45
KN 06
Extraction of pharmaceuticals from biological fluids by electromembrane extraction
|
||
| 9h50 |
9h50
FC 15
Mapping the lipid landscape of MASLD: insights into disease progression through lipidomic patterns
|
|||
| 10h00 |
10h00
FC 16
Pharmacokinetic profiling and preclinical evaluation of the FPR2 agonist MR-39: a chromatography-based bioanalytical approach supporting CNS drug development for Autism Spectrum Disorder
|
|||
| 10h10 |
10h10
FC 17
High-Throughput UPLC-MS/MS Quantification of Lyso-Gb3 and Its Analogues from Dried Blood Spots for Clinical Application in Fabry Disease
|
|||
| 10h15 |
10h15
OC 01
Advanced Technologies in Pharmaceutics and Biomedicine: Bridging Solid-State Materials and Live-Cell Dynamics with Raman Spectroscopy
|
10h15
OC 07
Method development for quantitation of nine nitazenes in whole blood combining volumetric microsampling and mass spectrometry
|
||
| 10h20 |
10h20
Coffee Break |
|||
| 10h35 |
10h35
FC 01
Rapid detection and quantification of tobacco additives using MIR and NIR Spectroscopy
|
10h35
FC 08
Optimized Extraction and Characterization of Polyphenols from Microalgae Using Green Techniques
|
||
| 10h45 |
10h45
FC 02
Advances in hardware design and function of the new timsOmni MS platform
|
10h45
FC 09
Urine microsampling and fully automated sample treatment for cannabinoid analysis
|
||
| 10h50 |
10h50
KN 11
Proteomics Tools in Drug Discovery
|
|||
| 10h55 |
10h55
Coffee Break |
10h55
Coffee Break |
||
| 11h20 |
11h20
KN 03
Analysis of flavonoids – still a challenge?
|
11h20
KN 07
Shaping Quality Control of Biopharmaceuticals with Analytical Quality by Design
|
11h20
OC 13
Multi-platform Metabolomics of Day-1 Embryo Culture Media for Early Prediction of Embryo Development Success
|
|
| 11h40 |
11h40
PL 04
The challenges of the analysis of novel pharmaceutical entities and the nitrosamines
|
|||
| 11h50 |
11h50
OC 02
Sustainable Valorization of Allium cepa PDO Leaves: Comprehensive Profiling and Antioxidant Metabolite Characterization via an Advanced Online LC×LC-HRMS Approach
|
11h50
OC 08
Determination of ethylene oxide residues in sterilized pharmaceutical products via full evaporation hesadspace – gas chromatography
|
||
| 12h10 |
12h10
OC 03
Antioxidant activity of the sulfated metabolite of 5-(3‘,4’-dihydroxyphenyl)-γ-valerolactone: role of aryl sulfatase activation in inflammatory conditions
|
12h10
OC 09
Pharmaceuticals in The Environment: Recent Progresses for An Effective and Responsible Environmental Risk Management
|
||
| 12h30 |
12h30
OC 04
A novel methodology for removing chlorophylls from plant matrices: a key step for gaining reliable analytical results
|
12h30
FC 10
Stability study of quercetin by chemometric tools for instrumental data analysis
|
12h35
Closing Ceremony |
|
| 12h40 |
12h40
FC 11
Development and validation of a cost-effective LC-UV method for screening and assay of antimicrobial medicines
|
12h45
Farewell Drink |
||
| 12h50 |
12h50
FC 03
Characterization and Antioxidant Activity of Hericium erinaceus: Insights from UHPLC-ESI-MS/MS Analysis
|
|||
| 13h00 |
13h00
Lunch |
13h00
Lunch |
||
| 14h00 |
14h00
Poster Session |
14h00
Poster Session |
||
| 15h00 |
15h00
KN 04
Innovative chromatographic strategies to improve the characterization of oligonucleotides
|
15h00
KN 08
Empowering selectivity in pharmaceutical analysis by two-dimensional liquid chromatography
|
||
| 15h30 |
15h30
FC 04
LC-MS/MS-Based Profiling of hIDO1 Inhibition for Preclinical Evaluation of Novel Cancer Immunometabolic Therapeutics
|
15h30
OC 10
Analysis of isomeric drugs of abuse: Current challenges and possible solutions
|
||
| 15h40 |
15h40
FC 05
Practical Impact of LC Connection and Tubing Setup on Method Reproducibility and Transfer
|
|||
| 15h50 |
15h50
FC 06
Agilent InfinityLab Pro iQ Plus single quadrupole mass spectrometer for protein glycosylation and impurity profiling
|
15h50
FC 12
Multiple heart-cutting achiral-chiral LC-LC analysis of branched-chain amino acids in food supplements
|
||
| 16h00 |
16h00
Coffee Break |
16h00
Coffee Break |
||
| 16h30 |
Registration |
16h30
KN 05
Approaches and strategies in assessing drug metabolism in early and preclinical drug development: application to our medicinal chemistry projects
|
16h30
KN 09
Multi-attribute method (MAM): from origin to new horizons
|
|
| 17h00 |
17h00
OC 05
Identification and Quantification of a Novel Cannabidiol (CBD) Metabolite in Rat Plasma, Brain, and Liver by LC-MS/MS Analysis
|
17h00
OC 11
Glycoform Fingerprints: Unlocking Human Monoclonal Antibody Glycosylation for Glycoengineering and Vaccine Innovation
|
||
| 17h20 |
17h20
OC 06
Evaluation of PTeCA (1-H-pyrrole-2,3,4,5-tetracarboxylic acid) in in vivo and in vitro hair matrix as a marker of oxidative cosmetic treatment in forensic hair testing
|
17h20
FC 13
Exploring Kidney Molecular Alterations Induced by High-Salt Intake in a Salt-Sensitive Hypertensive Mouse Model via Cutting-Edge LFQ Proteomics
|
||
| 17h30 |
17h30
Welcome Ceremony |
17h30
FC 14
HPV virus-like particle characterization by SEC and AF4 coupled with multi-angle light scattering
|
||
| 17h40 |
17h40
FC 07
Use of Surrogate Matrices for Accurate Quantification of Endogenous Amino Acids in Kidney Disease Samples
|
|||
| 18h00 |
18h00
PL 01
The New Era of Pharmaceutical Analysis: An Industry Perspective
|
|||
| 18h45 |
18h45
KN 01
The Biophysics Unit at Human Technopole: highlights and lessons from our first years of support to scientists
|
|||
| 19h30 |
Welcome Cocktail |
|||
| 20h00 |
VIP Dinner |
Social Dinner |